Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion type Assertion NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_head.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion wasGeneratedBy ECO_0000203 NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion wasDerivedFrom lhgdn-20090331 NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion SIO_000772 14507635 NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion evidence source_evidence_literature NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.